Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke

Stroke

Volumn 32, Issue 1, 2001, Pages 133-138

  Di Napoli, Mario ^a,b   Papa, Francesca ^a   Bocola, Vittorio ^a  

^a Casa di Cura Villa Pini d'Abruzzo Policlinico Abano Terme   (Italy)

^b Casa di Cura Villa Pini d'Abruzzo ^*  (Italy)

Author keywords

C reactive protein; Fibrinogen; Prognosis; Risk factors; Stroke, ischemic

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; STROKE; SURVIVAL;

EID: 0035157347     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.32.1.133     Document Type: Article

References (37)

1. Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors
2. Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly
3. Haemostatic function and cardiovascular death: Early results of a prospective study
4. Plasma fibrinogen: A major coronary risk factor
5. Fibrinogen and risk of cardiovascular disease
6. Fibrinogen and factor VII in the prediction of coronary risk
7. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease
8. Association of recurrent myocardial infarction with hemostatic factors
9. Haematological prognostic indices after myocardial infarction: Evidence from the Diet and Reinfarction Trial (DART)
10. Fibrinogen is a predictor of mortality in coronary heart disease patients
11. Fibrinogen as a cardiovascular risk factor: A metaanalysis and review of literature
12. Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors
13. Influence of platelet size on outcome after myocardial infarction
14. A six year prospective study of fibrinogen and other risk factors associated with mortality in stable claudicants
15. Pathobiology of ischaemic stroke: An integrated view
16. C-reactive protein (CRP) as outcome predictor after first-ever ischemic stroke
17. C-reactive protein after first-ever ischemic stroke
18. C-reactive protein and outcome after ischemic stroke
19. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke
20. C-reactive protein and outcome after first-ever ischemic stroke
21. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
22. The Stroke Data Bank: Design, methods, and baseline characteristics
23. The Canadian Neurological Scale: A preliminary study in acute stroke
24. Functional evaluation: The Barthel Index
25. Classification and natural history of clinically identifiable subtypes of cerebral infarction
26. The Harvard Cooperative Stroke Registry: A prospective registry
27. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
28. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
29. Persistent inflammatory response in stroke survivors
30. High stroke incidence in the prospective community-based L'Aquila Registry (1994-1998): First year's results
31. Infection, inflammation, and cerebrovascular ischemia
32. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor
33. Hemostatic markers in acute ischemic stroke: Association with stroke type, severity, and outcome
34. Hyper-coagulability in acute stroke: Prognostic significance
35. Inflammation in cardiovascular disease: Cart, horse, or both?
36. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain
37. Complement activation by C-reactive protein complexes